162 related articles for article (PubMed ID: 22366108)
1. Inhibition of pyrimidine and purine nucleoside phosphorylases by a 3,5-dichlorobenzoyl-substituted 2-deoxy-D-ribose-1-phosphate derivative.
Vande Voorde J; Quintiliani M; McGuigan C; Liekens S; Balzarini J
Biochem Pharmacol; 2012 May; 83(10):1358-63. PubMed ID: 22366108
[TBL] [Abstract][Full Text] [Related]
2. [Purine and pyrimidine nucleoside phosphorylases - remarkable enzymes still not fully understood].
Bzowska A
Postepy Biochem; 2015; 61(3):260-73. PubMed ID: 26677573
[TBL] [Abstract][Full Text] [Related]
3. Pentose phosphates in nucleoside interconversion and catabolism.
Tozzi MG; Camici M; Mascia L; Sgarrella F; Ipata PL
FEBS J; 2006 Mar; 273(6):1089-101. PubMed ID: 16519676
[TBL] [Abstract][Full Text] [Related]
4. Structural analyses reveal two distinct families of nucleoside phosphorylases.
Pugmire MJ; Ealick SE
Biochem J; 2002 Jan; 361(Pt 1):1-25. PubMed ID: 11743878
[TBL] [Abstract][Full Text] [Related]
5. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
Miles RW; Tyler PC; Furneaux RH; Bagdassarian CK; Schramm VL
Biochemistry; 1998 Jun; 37(24):8615-21. PubMed ID: 9628722
[TBL] [Abstract][Full Text] [Related]
6. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
[TBL] [Abstract][Full Text] [Related]
7. 1.45 A resolution crystal structure of recombinant PNP in complex with a pM multisubstrate analogue inhibitor bearing one feature of the postulated transition state.
Chojnowski G; Breer K; Narczyk M; Wielgus-Kutrowska B; Czapinska H; Hashimoto M; Hikishima S; Yokomatsu T; Bochtler M; Girstun A; Staroń K; Bzowska A
Biochem Biophys Res Commun; 2010 Jan; 391(1):703-8. PubMed ID: 19944078
[TBL] [Abstract][Full Text] [Related]
8. Novel multisubstrate inhibitors of mammalian purine nucleoside phosphorylase.
Toms AV; Wang W; Li Y; Ganem B; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1449-58. PubMed ID: 16239721
[TBL] [Abstract][Full Text] [Related]
9. Characterization of pyrimidine nucleoside phosphorylase of Mycoplasma hyorhinis: implications for the clinical efficacy of nucleoside analogues.
Vande Voorde J; Gago F; Vrancken K; Liekens S; Balzarini J
Biochem J; 2012 Jul; 445(1):113-23. PubMed ID: 22475552
[TBL] [Abstract][Full Text] [Related]
10. Purine nucleoside phosphorylase: its use in a spectroscopic assay for inorganic phosphate and for removing inorganic phosphate with the aid of phosphodeoxyribomutase.
Nixon AE; Hunter JL; Bonifacio G; Eccleston JF; Webb MR
Anal Biochem; 1998 Dec; 265(2):299-307. PubMed ID: 9882406
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of pyrimidine bases and nucleosides by pyrimidine-nucleoside phosphorylases in cultured human lymphoid cells.
Pérignon JL; Bories DM; Houllier AM; Thuillier L; Cartier PH
Biochim Biophys Acta; 1987 Apr; 928(2):130-6. PubMed ID: 3567226
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of 2'-deoxyguanosine cytotoxicity by a novel inhibitor of purine nucleoside phosphorylase, 8-amino-9-benzylguanine.
Shewach DS; Chern JW; Pillote KE; Townsend LB; Daddona PE
Cancer Res; 1986 Feb; 46(2):519-23. PubMed ID: 3079664
[TBL] [Abstract][Full Text] [Related]
13. Exploring new inhibitors of Plasmodium falciparum purine nucleoside phosphorylase.
Cui H; Ruda GF; Carrero-Lérida J; Ruiz-Pérez LM; Gilbert IH; González-Pacanowska D
Eur J Med Chem; 2010 Nov; 45(11):5140-9. PubMed ID: 20817362
[TBL] [Abstract][Full Text] [Related]
14. Structures for the potential drug target purine nucleoside phosphorylase from Schistosoma mansoni causal agent of schistosomiasis.
Pereira HD; Franco GR; Cleasby A; Garratt RC
J Mol Biol; 2005 Oct; 353(3):584-99. PubMed ID: 16182308
[TBL] [Abstract][Full Text] [Related]
15. Transition state analogue inhibitors of purine nucleoside phosphorylase from Plasmodium falciparum.
Kicska GA; Tyler PC; Evans GB; Furneaux RH; Kim K; Schramm VL
J Biol Chem; 2002 Feb; 277(5):3219-25. PubMed ID: 11707439
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase from Bacillus stearothermophilus TH 6-2.
Hamamoto T; Noguchi T; Midorikawa Y
Biosci Biotechnol Biochem; 1996 Jul; 60(7):1179-80. PubMed ID: 8782414
[TBL] [Abstract][Full Text] [Related]
17. Guanine, pyrazolo[3,4-d]pyrimidine, and triazolo[4,5-d]pyrimidine (8-azaguanine) phosphonate acyclic derivatives as inhibitors of purine nucleoside phosphorylase.
Beauchamp LM; Tuttle JV; Rodriguez ME; Sznaidman ML
J Med Chem; 1996 Feb; 39(4):949-56. PubMed ID: 8632418
[TBL] [Abstract][Full Text] [Related]
18. Production of 5-methyluridine by immobilized thermostable purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase from Bacillus stearothermophilus JTS 859.
Hori N; Watanabe M; Sunagawa K; Uehara K; Mikami Y
J Biotechnol; 1991 Feb; 17(2):121-31. PubMed ID: 1367490
[TBL] [Abstract][Full Text] [Related]
19. Localization of purine and pyrimidine nucleoside phosphorylases in heart, kidney, and liver.
Rubio R; Berne RM
Am J Physiol; 1980 Dec; 239(6):H721-30. PubMed ID: 6778226
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.
Gregus Z; Roos G; Geerlings P; Németi B
Toxicol Sci; 2009 Aug; 110(2):282-92. PubMed ID: 19478237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
